New Products

Premium

Aushon BioSystems launched this week new human multiplex biomarker panels for the quantification of eight protein biomarkers related to drug-induced kidney damage.

The panels are validated for analysis of the following biomarkers in urine samples: KIM-1, clusterin, TIMP-1, VEGF, trefoil factor-3, osteopontin, EGF, and NGAL. The panels were developed with the Aushon SearchLight protein array technology and feature a 3.5 hour protocol similar to standard plate-based ELISAs, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.